Holen Sie sich die Stockscreener-App
1.08
4.85%
0.05
Schlusskurs vom Vortag:
$1.03
Offen:
$1.04
24-Stunden-Volumen:
9.25M
Relative Volume:
0.33
Marktkapitalisierung:
$408.09M
Einnahmen:
$199.32M
Nettoeinkommen (Verlust:
$-272.74M
KGV:
-0.554
EPS:
-1.9494
Netto-Cashflow:
$-63.86M
1W Leistung:
-1.82%
1M Leistung:
-13.60%
6M Leistung:
-34.15%
1J Leistung:
-42.86%
1-Tages-Spanne:
$1.04
$1.11
1-Wochen-Bereich:
$1.02
$1.15
52-Wochen-Spanne:
$0.77
$2.38
Canopy Growth Corporation Stock (CGC) Company Profile
Firmenname
Canopy Growth Corporation
Sektor
Telefon
855-558-9333
Adresse
1 Hershey Drive, Smiths Falls, ON
Compare CGC vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
1.08 | 389.20M | 199.32M | -272.74M | -63.86M | -1.9494 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.46 | 58.03B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.65 | 55.37B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.20 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.98 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.66 | 20.50B | 3.13B | 1.27B | 1.12B | 26.39 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-10 | Hochstufung | The Benchmark Company | Sell → Hold |
| 2023-04-04 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-11-02 | Eingeleitet | Bernstein | Underperform |
| 2022-10-26 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2022-06-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-03-22 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-12-22 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-12-20 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-12-07 | Eingeleitet | Wells Fargo | Underweight |
| 2021-11-18 | Eingeleitet | Barclays | Equal Weight |
| 2021-11-08 | Herabstufung | CIBC | Neutral → Sector Underperform |
| 2021-11-08 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-11-08 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-10-01 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-08-12 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-06-02 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2021-05-25 | Hochstufung | MKM Partners | Neutral → Buy |
| 2021-04-28 | Fortgesetzt | BofA Securities | Buy |
| 2021-02-24 | Herabstufung | Jefferies | Hold → Underperform |
| 2021-02-10 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-02-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-02-05 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-04 | Hochstufung | CFRA | Buy → Strong Buy |
| 2020-06-01 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-06-01 | Herabstufung | Bryan Garnier | Neutral → Sell |
| 2020-06-01 | Herabstufung | CIBC | Sector Outperform → Neutral |
| 2020-06-01 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-01 | Herabstufung | Stifel | Buy → Sell |
| 2020-05-22 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-04-16 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-01-28 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-12-12 | Bestätigt | Cantor Fitzgerald | Neutral |
| 2019-11-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-15 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-10-14 | Herabstufung | Seaport Global Securities | Buy → Neutral |
| 2019-10-11 | Herabstufung | Jefferies | Hold → Underperform |
| 2019-09-27 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-09-18 | Eingeleitet | Oppenheimer | Perform |
| 2019-08-26 | Hochstufung | Seaport Global Securities | Neutral → Buy |
| 2019-07-17 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Canopy Growth Corporation Aktie (CGC) Neueste Nachrichten
Canopy Growth’s Stock Jumps on Q3 Earnings & MTL Acquisition - StocksToTrade
Promising Cannabis Stocks To ConsiderFebruary 13th - MarketBeat
Here’s the problem with Canopy Growth stock - Cantech Letter
(WEED) Stock Trading Blueprint (WEED:CA) - Stock Traders Daily
Should You Forget Canopy Growth and Buy This Magnificent Cannabis Stock Instead? - The Motley Fool
Is the Market Bullish or Bearish on Canopy Growth Corp? - Benzinga
Should Canopy Growth stock be in your portfolio post Q3 earnings? - MSN
Should Canopy Growth Stock Be in Your Portfolio Post Q3 Earnings? - The Globe and Mail
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Canopy Growth Corporation Postpones Annual General and Special Shareholders Meeting Due to Insufficient Quorum - Intellectia AI
Is It Time to Dump Your Shares of Canopy Growth Corp? - AOL.com
Promising Cannabis Stocks To Watch TodayFebruary 10th - MarketBeat
MTL Cannabis Presses Shareholders to Back Premium Takeover by Canopy Growth - TipRanks
MTL Cannabis Reminds MTL Shareholders to Vote FOR the Arrangement Resolution to Approve the Proposed Plan of Arrangement with Canopy Growth at the Upcoming Special Meeting of MTL Shareholders (2026-02-10) - Seeking Alpha
Canopy Growth Reports Substantial Loss Reduction in Q3 Earnings - AD HOC NEWS
(WEED) Proactive Strategies (WEED:CA) - Stock Traders Daily
Canopy Growth Reports Mixed Quarterly Results and Strategic Acquisition - AD HOC NEWS
Best Cannabis Stocks To ResearchFebruary 9th - MarketBeat
Canopy Growth’s Mixed Quarter: Losses Narrow but Earnings Miss - AD HOC NEWS
Canopy Growth Reports Sharply Narrowed Losses in Q3 - AD HOC NEWS
Is it time to dump your shares of Canopy Growth Corp? - MSN
Cannabis Stocks To Keep An Eye OnFebruary 8th - MarketBeat
Canopy Growth’s Narrowing Losses Met With Analyst Skepticism - AD HOC NEWS
Canopy Growth (TSX:WEED) Valuation Check After Narrowed Losses And New Shelf Registration - Yahoo Finance
Cannabis Stocks To ResearchFebruary 7th - MarketBeat
Canopy Growth signals positive adjusted EBITDA in fiscal 2027 amid MTL acquisition and expanding European focus - MSN
Canopy Growth Corporation (NASDAQ:CGC) Q3 2026 Earnings Call Transcript - Insider Monkey
When (WEED) Moves Investors should Listen (WEED:CA) - Stock Traders Daily
Wall Street Zen Downgrades Canopy Growth (NASDAQ:CGC) to Sell - MarketBeat
Canopy Growth Narrows Losses Amid Strategic Restructuring - AD HOC NEWS
Canopy Growth Q3 2026 Earnings Call Transcript - MarketBeat
Canopy Growth (CGC) Announces Sale of 18.71 Million Common Shares - GuruFocus
Canopy Growth Q3 Earnings Call Highlights - MarketBeat
Cannabis Stocks To Watch TodayFebruary 6th - MarketBeat
Canopy Growth Corp (CGC) Q3 2026 Earnings Call Highlights: Navigating Growth and Challenges in ... By GuruFocus - Investing.com Canada
Canopy Growth (NASDAQ:CGC) Posts Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
Earnings call transcript: Canopy Growth Q3 2026 misses EPS, beats revenue By Investing.com - Investing.com South Africa
Canopy Growth Corp (TSX:WEED) Shifts Focus While Tracking TSX Smallcap Index Today - Kalkine Media
Canopy’s domestic sales increase in Q3 2026 while international sales decline - StratCann
Earnings call transcript: Canopy Growth Q3 2026 misses EPS, beats revenue - Investing.com
WEED: Revenue growth, cost savings, and MTL acquisition position for positive EBITDA in 2027 - TradingView
WEED: Q3 delivered revenue growth, improved margins, and a stronger balance sheet, with MTL acquisition ahead - TradingView
Canopy Growth Reports Narrowed Losses Amid Strategic Overhaul - AD HOC NEWS
Stocks in play: Canopy Growth Corporation - Barchart.com
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? - The Globe and Mail
Canopy Growth posts mixed Q3 results, narrower loss amid ongoing cost cuts - Proactive financial news
Canopy Growth reports Q3 EPS (C$0.18) vs. (C$1.11) last year - TipRanks
Canopy Growth (CGC) Q3 FY2026 earnings: loss narrows by 49% - grafa.com
Canopy Growth Corporation (CGC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Canopy Growth Narrows Losses and Bolsters Balance Sheet as Canadian Cannabis Sales Rise - TipRanks
Canopy Growth Q3 Net Loss Narrows - marketscreener.com
Finanzdaten der Canopy Growth Corporation-Aktie (CGC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):